CERECOR

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc... 1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.

#SimilarOrganizations #People #Financial #Website #More

CERECOR

Industry:

Biopharma Biotechnology Health Care

Founded:

2011-01-01

Address:

Baltimore, Maryland, United States

Country:

United States

Website Url:

http://www.cerecor.com

Total Employee:

11+

Status:

Active

Contact:

410-522-8707

Email Addresses:

[email protected]

Total Funding:

133.34 M USD

Technology used in webpage:

SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA ASP.NET Amazon Virginia Region ReCAPTCHA V2

Similar Organizations

not_available_image

AcSentient

AcSentient develops and commercializes specialty, niche prescription drugs.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

h-jeffrey-wilkins_image

H. Jeffrey Wilkins
H. Jeffrey Wilkins Chief Medical Officer @ Cerecor
Chief Medical Officer
2020-02-01

not_available_image

Federica F. O&s;Brien
Federica F. O'Brien CFO @ Cerecor
CFO

phil-gutry_image

Phil Gutry
Phil Gutry Member of the Board of Director, Chair - Audit Committee @ Cerecor
Member of the Board of Director, Chair - Audit Committee
2015-04-01

james-harrell_image

James Harrell
James Harrell CCO @ Cerecor
CCO

Founder

blake-m-paterson_image

Blake M. Paterson

not_available_image

Isaac Blech

Stock Details

Company's stock symbol is NASDAQ:CERC

Acquisitions List

Date	Company	Article	Price
2019-12-05	Aevi Genomic Medicine	Aevi Genomic Medicine acquired by Cerecor	22.6 M USD
2018-09-25	Ichorion Therapeutics	Ichorion Therapeutics acquired by Cerecor	26.6 M USD
2017-11-17	Zylera Pharmaceuticals	Zylera Pharmaceuticals acquired by Cerecor	N/A

Investors List

horizon-technology-finance_image

Official Site Inspections

http://www.cerecor.com

Host Informations
Whois Informations

Loading ...